200 related articles for article (PubMed ID: 25610752)
1. Rhodiola rosea therapy for major depressive disorder: a study protocol for a randomized, double-blind, placebo- controlled trial.
Mao JJ; Li QS; Soeller I; Xie SX; Amsterdam JD
J Clin Trials; 2014 Jun; 4():170. PubMed ID: 25610752
[TBL] [Abstract][Full Text] [Related]
2. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.
Mao JJ; Xie SX; Zee J; Soeller I; Li QS; Rockwell K; Amsterdam JD
Phytomedicine; 2015 Mar; 22(3):394-9. PubMed ID: 25837277
[TBL] [Abstract][Full Text] [Related]
3. Rhodiola rosea L. as a putative botanical antidepressant.
Amsterdam JD; Panossian AG
Phytomedicine; 2016 Jun; 23(7):770-83. PubMed ID: 27013349
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial.
Gao L; Wu C; Liao Y; Wang J
J Affect Disord; 2020 Mar; 265():99-103. PubMed ID: 32090788
[TBL] [Abstract][Full Text] [Related]
5. Rhodiola rosea for mental and physical fatigue in nursing students: a randomized controlled trial.
Punja S; Shamseer L; Olson K; Vohra S
PLoS One; 2014; 9(9):e108416. PubMed ID: 25268730
[TBL] [Abstract][Full Text] [Related]
6. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
Olsson EM; von Schéele B; Panossian AG
Planta Med; 2009 Feb; 75(2):105-12. PubMed ID: 19016404
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
Darbinyan V; Aslanyan G; Amroyan E; Gabrielyan E; Malmström C; Panossian A
Nord J Psychiatry; 2007; 61(5):343-8. PubMed ID: 17990195
[TBL] [Abstract][Full Text] [Related]
8. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial.
Otte C; Chae WR; Nowacki J; Kaczmarczyk M; Piber D; Roepke S; Märschenz S; Lischewski S; Schmidt S; Ettrich B; Grabe HJ; Hegerl U; Hinkelmann K; Hofmann T; Janowitz D; Junghanns K; Kahl KG; Klein JP; Krueger THC; Leicht G; Prvulovic D; Reif A; Schoettle D; Strauss M; Westermair A; Friede T; Gold SM
BMJ Open; 2020 Dec; 10(12):e040119. PubMed ID: 33262189
[TBL] [Abstract][Full Text] [Related]
10. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
11. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, open-label, exploratory clinical trial with
Kasper S; Dienel A
Neuropsychiatr Dis Treat; 2017; 13():889-898. PubMed ID: 28367055
[TBL] [Abstract][Full Text] [Related]
13. The authenticity and quality of Rhodiola rosea products.
Booker A; Jalil B; Frommenwiler D; Reich E; Zhai L; Kulic Z; Heinrich M
Phytomedicine; 2016 Jun; 23(7):754-62. PubMed ID: 26626192
[TBL] [Abstract][Full Text] [Related]
14. Acute Rhodiola rosea intake can improve endurance exercise performance.
De Bock K; Eijnde BO; Ramaekers M; Hespel P
Int J Sport Nutr Exerc Metab; 2004 Jun; 14(3):298-307. PubMed ID: 15256690
[TBL] [Abstract][Full Text] [Related]
15. The effects of an acute dose of Rhodiola rosea on endurance exercise performance.
Noreen EE; Buckley JG; Lewis SL; Brandauer J; Stuempfle KJ
J Strength Cond Res; 2013 Mar; 27(3):839-47. PubMed ID: 23443221
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study.
Montgomery SA; Mansuy L; Ruth A; Bose A; Li H; Li D
J Clin Psychiatry; 2013 Apr; 74(4):363-9. PubMed ID: 23656841
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial.
Farajollahi-Moghadam M; Sanjari-Moghaddam H; Ghazizadeh Hasemi M; Sanatian Z; Talaei A; Akhondzadeh S
Int Clin Psychopharmacol; 2021 May; 36(3):140-146. PubMed ID: 33724254
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial.
Mao JJ; Li QS; Soeller I; Rockwell K; Xie SX; Amsterdam JD
J Clin Trials; 2014 Nov; 4(5):. PubMed ID: 29057164
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial.
Khadivi A; Shobeiri P; Momtazmaneh S; Samsami FS; Shalbafan M; Shirazi E; Akhondzadeh S
Psychopharmacology (Berl); 2022 Feb; 239(2):551-559. PubMed ID: 35072758
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
